/ Strategy

At ARCOGrants, we help clients take a proactive approach to grant funding with a tailored, long-term grant strategy. Rather than pursuing funding opportunities on a case-by-case basis, we work closely with our clients to develop a roadmap that forecasts SBIR/STTR programs opportunities one to two years in advance.

Play Video

/ About the service

This way, clients can focus on the grants that align most closely with their company’s growth objectives, ensuring a strong match between their project goals and the funding agency’s priorities.
Our approach starts with defining a clear funding goal that serves as the foundation of the grant proposal. This involves evaluating your product pipeline, assessing the potential applications of your technology (including grant medical devices, grant biomedicine, and grant biotech), and identifying the key milestones you aim to achieve with the support of grant funding. By doing so, we ensure that your funding goals are specific (what exactly you want to achieve?), measurable (how you will know when you have achieved it?), achievable (realistic given your resources), relevant (aligned with your overall strategy), and time-bound (with a clear timeline) (SMART), giving you a strong, purpose-driven foundation for each proposal.
With ARCOGrants, you’re building a diversified, well-planned funding path that supports your company’s mission, aligns with your development timeline, and maximizes your chances of securing funding.

/ Benefits of a clear grant strategy

Clear and Defined Funding Program-Company Fit: Increases chances of securing funding while avoiding unnecessary expenditure of resources (time, personnel, budget), resulting in stronger, higher-probability grant proposals.
Diversified Funding Portfolio: Enables pursuit of multiple grants across different sources, reducing the risk associated with relying on a single funding source.
Alignment with Long-Term Goals: Keeps funding efforts aligned with broader company objectives, ensuring that each grant pursued supports the overall mission, product pipeline, and strategic roadmap. Allows prioritization of the most relevant opportunities, minimizing the pursuit of low-priority or misaligned grants.

/ Testimonials

“Working with Ana was an absolutely pleasurable experience. Ana took lead on the project and built out every component to ensure timely & accurate submission, information, communication & writing, as well as overall professionalism. She made a monumental and stressful process seem relatively easy all while maintaining high quality work. I highly recommend her for all of your grant writing needs!”

Nicholas Sokol, PhD

Founder & CEO, Algaeo

Joven con barba posando con un aparato rectangular en la mano

“I have worked with Ana in the preparation of NSF grants, in which she was incredibly valuable in ensuring our grant application had the proper content, focus, and format. Having a grant writer like Ana who truly understands the process and what the agencies are looking for is invaluable. We are now working together on new grant proposals for other agencies including NIH and DOD. I would highly recommend working with her.”

Dalton Signor

Founder & CEO, MIIST Therapeutics

Selfie de un hombre con perilla y bigote

"A massive thank you to Ana for her exceptional contributions throughout our NSF SBIR Phase 1 application. Her collaborative spirit and expert knowledge were pivotal in securing this funding, especially as this was our first-time application for NSF SBIR Phase I. We couldn’t have achieved this milestone without you, Ana!”

Yoshinori Fukazawa

Co-Founder of Eugit Therapeutics

Mujer de mediana edad posa con media sonrisa. Lleva unos aros como pendientes.

"I have had the pleasure of working with Ana on our successful Phase 1 NSF grant proposal and submission of our Phase 2 proposal, as well. Ana is incredibly knowledgeable about the grant process and was invaluable in helping us navigate it successfully. She kept our team focused and on track and provided important insight into both the content and format of our proposal. I look forward to working with her again in the future."

Iga Hallberg

Co-Founder & COO, Ummino

"Aperiam learned it had a white paper due ~ 10 days before submission, and while we were confident our technology fit the BAA our team was tied up and needed help. We had worked with Ana once before and were pleased with her clarity of thought and communication, but realized this timeline would be a stretch for even a strong writer. Ana delivered a remarkable while paper on time. Her faithful communication, intellectual acuity, and attention to detail are a priceless help to our team. We all look forward to working with her again in the future."

Austin Cole, PhD

Founder & CEO, Aperiam Bio

Hombre joven con pelo negro y barba lleva un traje mientras posa para la foto

"I had the pleasure of working with Ana Ortiz on our successful NSF grant proposal. Ana's attention to detail and ability to clearly articulate our company's meeds and goals made all the difference in our successful application for this government grant funding. Her expertise and guidance were invaluable, and her dedication to our project was evident throughout the process. Ana's thorough understanding of the grant application process and requirements allowed us to unlock a key opportunity for our company. Her professionalism, communication skills, and work ethic made it a pleasure to collaborate with her on this project. I highly recommend Ana Ortiz to anyone seeking a talented and reliable grant expert. Her exceptional skills and dedication to her work make her an asset to any team. Thank you, Ana, for all your hard work!"

Idicula Matthew

Co-Founder & CEO, Hera Health Solutions

Joven de pelo moreno y con camisa celeste

"We are very pleased to provide a recommendation for Ana Ortiz, who played an instrumental role in securing our recent grant approval with NIA on the first submission! From the outset, Ana demonstrated exceptional expertise in understanding our project needs and aligning them with the funder's priorities. Her prior experiences, thorough research, strategic approach, and meticulous attention to detail were so evident throughout the grant writing process. Her ability to craft compelling narratives that resonate with reviewers effectively conveys the significance of our work. Not only did Ana deliver a high-quality proposal, she also provided valuable insights and guidance that helped refine our approach to enhance our application. Her professionalism and dedication were crucial to our success, and we have no doubt that her skills will continue to benefit any organization fortunate enough to work with her. If you need a successful grant writer, we recommend Ana Ortiz at ArcoGrants. She is very talented, commiPed, and truly exceptional at what she does.”

Albert Alaan

Senior UX Analyst, 231 Sheep

"Ana was instrumental in our success with the NSF Phase 1 grant. Her diligence and meticulous management of timelines ensured everything was on track. She contributed valuable insights to our business plan and was consistently professional and pleasant to work with. I highly recommend Ana and look gorward to working with her again in the future."

Nizar Batada, PhD

Founder & CEO, Eugit Therapeutics

/ Success Cases in Non‑Dilutive Funding, Biotech & Health

Eugit Therapeutics

Ummino (Formerly Botany AI)

Hera Health Solutions

231 Sheep

/ FAQs

What is your long-term grant strategy service and how does it differ from applying to individual funding opportunities?

Our service focuses on building a proactive, long-term grant strategy rather than pursuing funding on a case-by-case basis. We develop a structured roadmap that anticipates SBIR/STTR opportunities one to two years in advance, ensuring that each application aligns with your company’s growth trajectory and reduces inefficient use of time and resources.

How do you define a strong funding strategy for SBIR and STTR programs?

We begin by establishing a clear and specific funding objective aligned with your product pipeline and commercialization goals. This includes evaluating your technology applications across areas such as medical devices, biomedicine, and biotech, and identifying key development milestones. Each objective is structured using SMART criteria—specific, measurable, achievable, relevant, and time-bound—to ensure clarity and execution feasibility.

How does a grant strategy improve the success rate of funding applications?

A well-defined strategy ensures that every grant pursued is aligned with both funding agency priorities and your company’s long-term objectives. This alignment significantly increases proposal competitiveness, improves reviewer relevance, and reduces the risk of investing resources in low-probability opportunities.

Can a grant strategy help diversify funding sources beyond SBIR and STTR programs?

Yes. A structured grant strategy enables companies to identify and pursue multiple funding opportunities across different agencies and programs. This diversification reduces dependency on a single funding source and creates a more stable and resilient non-dilutive funding portfolio.

How does ARCO Grants ensure that funding efforts stay aligned with long-term business goals?

We integrate your funding roadmap with your broader company mission, product pipeline, and development timeline. This ensures that every grant pursued contributes directly to strategic milestones, allowing for better prioritization of opportunities and avoiding misalignment with long-term objectives.